SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Monica Logan, Shannon M. Hawkins, Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies, Clinical Science, 2015, 128, 3, 153

    CrossRef

  2. 2
    Hanwen Xu, Lucia Pirisi, Kim E. Creek, Six1 overexpression at early stages of HPV16-mediated transformation of human keratinocytes promotes differentiation resistance and EMT, Virology, 2015, 474, 144

    CrossRef

  3. 3
    M O'Connor, L Costello, J Murphy, W Prendiville, CM Martin, JJ O'Leary, L Sharp, ‘I don't care whether it's HPV or ABC, I just want to know if I have cancer.’ Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study, BJOG: An International Journal of Obstetrics & Gynaecology, 2014, 121, 11
  4. 4
    Diane Davis Davey, Robert Goulart, Ritu Nayar, 2013 Statement on Human Papillomavirus DNA Test Utilization, Journal of the American Society of Cytopathology, 2014, 3, 2, 87

    CrossRef

  5. 5
    A Kisser, I Zechmeister-Koss, A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology, BJOG: An International Journal of Obstetrics & Gynaecology, 2014, 121, 13
  6. 6
    L. Stewart Massad, Xianhong Xie, Howard Minkoff, Teresa M. Darragh, Gypsyamber D’Souza, Lorraine Sanchez-Keeland, D. Heather Watts, Christine Colie, Howard D. Strickler, Abnormal Pap Tests and Human Papillomavirus Infections Among HIV-Infected and Uninfected Women Who Have Sex With Women, Journal of Lower Genital Tract Disease, 2014, 18, 1, 50

    CrossRef

  7. 7
    Marc Arbyn, Freija Verdoodt, Peter J F Snijders, Viola M J Verhoef, Eero Suonio, Lena Dillner, Silvia Minozzi, Cristina Bellisario, Rita Banzi, Fang-Hui Zhao, Peter Hillemanns, Ahti Anttila, Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis, The Lancet Oncology, 2014, 15, 2, 172

    CrossRef

  8. 8
    Ling Zhang, Hui Kong, Chien Ting Chin, Shaoxiong Liu, Xinmin Fan, Tianfu Wang, Siping Chen, Automation-assisted cervical cancer screening in manual liquid-based cytology with hematoxylin and eosin staining, Cytometry Part A, 2014, 85, 3
  9. 9
    R Landy, H Birke, A Castanon, P Sasieni, Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years, British Journal of Cancer, 2014, 110, 7, 1841

    CrossRef

  10. You have free access to this content10
    Robert A. Smith, Deana Manassaram-Baptiste, Durado Brooks, Vilma Cokkinides, Mary Doroshenk, Debbie Saslow, Richard C. Wender, Otis W. Brawley, Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening, CA: A Cancer Journal for Clinicians, 2014, 64, 1
  11. 11
    Helen Dinkelspiel, Barbara Fetterman, Nancy Poitras, Walter Kinney, J. Thomas Cox, Thomas Lorey, Philip E. Castle, Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap, Journal of Lower Genital Tract Disease, 2014, 18, 1, 57

    CrossRef

  12. 12
    Walter Kinney, William C. Hunt, Helen Dinkelspiel, Michael Robertson, Jack Cuzick, Cosette M. Wheeler, Cervical excisional treatment of young women: A population-based study, Gynecologic Oncology, 2014, 132, 3, 628

    CrossRef

  13. 13
    Kristen R. Moore, Jennifer S. Smith, Shannon K. Laughlin-Tommaso, Donna D. Baird, Cervical neoplasia–related factors and decreased prevalence of uterine fibroids among a cohort of African American women, Fertility and Sterility, 2014, 101, 1, 208

    CrossRef

  14. 14
    A. S. Rustagi, A. Kamineni, S. Weinmann, S. D. Reed, P. Newcomb, N. S. Weiss, Cervical Screening and Cervical Cancer Death Among Older Women: A Population-Based, Case-Control Study, American Journal of Epidemiology, 2014, 179, 9, 1107

    CrossRef

  15. 15
    Abdrabuh N. Shwter, Nor Azizan Abdullah, Mohammed A. Alshawsh, Abdulsamd Alsalahi, Maryam Hajrezaei, Amel A. Almaqrami, Sameer D. Salem, Mahmood A. Abdulla, Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats, Journal of Ethnopharmacology, 2014, 151, 3, 1194

    CrossRef

  16. 16
    Sandra D Isidean, François Coutlée, Eduardo L Franco, cobas®4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens, Expert Review of Molecular Diagnostics, 2014, 14, 1, 5

    CrossRef

  17. 17
    Warner K. Huh, Erin Williams, Joice Huang, Tommy Bramley, Nick Poulios, Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening, Applied Health Economics and Health Policy, 2014,

    CrossRef

  18. 18
    Cristina Morales Martínez, Sonia Tejuca Somoano, M. Luz Lamelas Suárez-Pola, Isabel Álvarez Miranda, Raquel Campomanes Sánchez, Cribado de cáncer cervical con citología y test del virus del papiloma humano cada 5 años: una realidad, Progresos de Obstetricia y Ginecología, 2014, 57, 4, 164

    CrossRef

  19. 19
    Nicole R. King, Kelly M. Kasper, Joanne K. Daggy, Brownsyne Tucker Edmonds, Current practice patterns in cervical cancer screening in Indiana, American Journal of Obstetrics and Gynecology, 2014, 210, 3, 265.e1

    CrossRef

  20. 20
    Shalanda A. Bynum, Daphnee A. Guillaume, Heather M. Brandt, Faith E. Fletcher, Does Knowledge Influence Pap Test Screening Among Young African-American Women?, Journal of Cancer Education, 2014, 29, 3, 478

    CrossRef

  21. 21
    Kristen B. Pytynia, Kristina R. Dahlstrom, Erich M. Sturgis, Epidemiology of HPV-associated oropharyngeal cancer, Oral Oncology, 2014, 50, 5, 380

    CrossRef

  22. 22
    Rosa Oncíns Torres, María Ángeles Aragón Sanz, María Dolores Comes García, Víctor Vallés Gallego, Ana Cortés Ramas, Evaluación de un nuevo protocolo de cribado de cáncer cervical con citología convencional y test del virus del papiloma humano, Progresos de Obstetricia y Ginecología, 2014, 57, 1, 14

    CrossRef

  23. 23
    Sang Ho Kim, Kyung A. Bae, Sang Yong Song, Dae Shick Kim, Evaluation of HPV GenoBlot Assay for screening and genotyping of human papillomavirus, BioChip Journal, 2014, 8, 1, 60

    CrossRef

  24. 24
    Jamie Bryant, Allison Boyes, Kimberley Jones, Rob Sanson-Fisher, Mariko Carey, Rae Fry, Examining and addressing evidence-practice gaps in cancer care: a systematic review, Implementation Science, 2014, 9, 1, 37

    CrossRef

  25. 25
    Hong Xiao, Lina Wu, Huixia Zheng, Ning Li, Huili Wan, Gang Liang, Yanglu Zhao, Jianfang Liang, Expression of Yes-Associated Protein in Cervical Squamous Epithelium Lesions, International Journal of Gynecological Cancer, 2014, 24, 9, 1575

    CrossRef

  26. 26
    Nicolas Wentzensen, Mark Schiffman, Filling a gap in cervical cancer screening programmes, The Lancet Oncology, 2014, 15, 3, 249

    CrossRef

  27. 27
    Amy Earley, Jenny L. Lamont, Issa J. Dahabreh, Janet Cowan, Sarah Feldman, Katrin Uhlig, Fluorescence In Situ Hybridization Testing for the Diagnosis of High-Grade Cervical Abnormalities, Journal of Lower Genital Tract Disease, 2014, 18, 3, 218

    CrossRef

  28. You have free access to this content28
    Jacqueline W. Miller, Vivien Hanson, Gale D. Johnson, Janet E. Royalty, Lisa C. Richardson, From cancer screening to treatment: Service delivery and referral in the National Breast and Cervical Cancer Early Detection Program, Cancer, 2014, 120, S16
  29. 29
    Priscilla Brebi, Leonel Maldonado, Maartje G Noordhuis, Carmen Ili, Pamela Leal, Patricia Garcia, Mariana Brait, Judit Ribas, Christina Michailidi, Jimena Perez, Ethan Soudry, Oscar Tapia, Pablo Guzman, Sergio Muñoz, Leander Van Neste, Wim Van Criekinge, Rafael Irizarry, David Sidransky, Juan C Roa, Rafael Guerrero-Preston, Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population, Epigenetics, 2014, 9, 2, 308

    CrossRef

  30. 30
    Patti E Gravitt, Anne F Rositch, HPV self-testing and cervical cancer screening coverage, The Lancet Oncology, 2014, 15, 2, 128

    CrossRef

  31. 31
    Karolina Louvanto, Myriam Chevarie-Davis, Agnihotram Venkata Ramanakumar, Eduardo Luis Franco, Alex Ferenczy, HPV testing with cytology triage for cervical cancer screening in routine practice, American Journal of Obstetrics and Gynecology, 2014, 210, 5, 474.e1

    CrossRef

  32. 32
    L Rodríguez-Carunchio, I Soveral, RDM Steenbergen, A Torné, S Martinez, P Fusté, J Pahisa, L Marimon, J Ordi, M Pino, HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis, BJOG: An International Journal of Obstetrics & Gynaecology, 2014, 121, 13
  33. 33
    Donatus U. Ekwueme, Vladislav J. Uzunangelov, Thomas J. Hoerger, Jacqueline W. Miller, Mona Saraiya, Vicki B. Benard, Ingrid J. Hall, Janet Royalty, Chunyu Li, Evan R. Myers, Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Women in the U.S., 1991–2007, American Journal of Preventive Medicine, 2014, 47, 3, 300

    CrossRef

  34. 34
    Anne F. Rositch, Rebecca G. Nowak, Patti E. Gravitt, Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009, Cancer, 2014, 120, 13
  35. 35
    Anna Maria Abadir, Ariella Lang, Talia Klein, Haim Arie Abenhaim, Influence of qualitative research on women's health screening guidelines, American Journal of Obstetrics and Gynecology, 2014, 210, 1, 44.e1

    CrossRef

  36. 36
    Nicolas Wentzensen, Barbara Fetterman, Diane Tokugawa, Mark Schiffman, Philip E. Castle, Shannon N. Wood, Eric Stiemerling, Nancy Poitras, Thomas Lorey, Walter Kinney, Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening, Cancer Cytopathology, 2014, 122, 12
  37. 37
    M. Safaeian, A. C. Rodriguez, Invited Commentary: Multiple Human Papillomavirus Infections and Type Replacement--Anticipating the Future After Human Papillomavirus Vaccination, American Journal of Epidemiology, 2014, 180, 11, 1076

    CrossRef

  38. 38
    Claudia Pileggi, Domenico Flotta, Aida Bianco, Carmelo G.A. Nobile, Maria Pavia, Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials, International Journal of Cancer, 2014, 135, 1
  39. 39
    Qin-jing Pan, Shang-ying Hu, Hui-qin Guo, Wen-hua Zhang, Xun Zhang, Wen Chen, Jian Cao, Yong Jiang, Fang-hui Zhao, You-lin Qiao, Liquid-based cytology and human papillomavirus testing: A pooled analysis using the data from 13 population-based cervical cancer screening studies from China, Gynecologic Oncology, 2014, 133, 2, 172

    CrossRef

  40. 40
    You-Lin Qiao, Jose Jeronimo, Fang-Hui Zhao, Johannes Schweizer, Wen Chen, Melissa Valdez, Peter Lu, Xun Zhang, Le-Ni Kang, Pooja Bansil, Proma Paul, Charles Mahoney, Marthe Berard-Bergery, Ping Bai, Roger Peck, Jing Li, Feng Chen, Mark H. Stoler, Philip E. Castle, Lower cost strategies for triage of human papillomavirus DNA-positive women, International Journal of Cancer, 2014, 134, 12
  41. 41
    Julio Cesar Teixeira, Sophie Françoise Mauricette Derchain, Eliane R. Zambelli Oliveira, Círbia S. Campos Teixeira, Liliana A.L.A. Andrade, Carlos Eduardo Bacchi, Luiz Carlos Zeferino, Microinvasive Adenocarcinoma of the Cervix in a Young Woman Vaccinated Against Human Papillomavirus, Journal of Lower Genital Tract Disease, 2014, 18, 2, E50

    CrossRef

  42. 42
    Antonio Carlos de Freitas, Eliane Campos Coimbra, Maria da Conceição Gomes Leitão, Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1845, 2, 91

    CrossRef

  43. 43
    Vicki B. Benard, Mona Saraiya, April Greek, Nikki A. Hawkins, Katherine B. Roland, Diane Manninen, Donatus U. Ekwueme, Jacqueline W. Miller, Elizabeth R. Unger, Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening, Journal of Women's Health, 2014, 23, 3, 197

    CrossRef

  44. 44
    Sarah M. Peitzmeier, Karishma Khullar, Sari L. Reisner, Jennifer Potter, Pap Test Use Is Lower Among Female-to-Male Patients Than Non-Transgender Women, American Journal of Preventive Medicine, 2014, 47, 6, 808

    CrossRef

  45. 45
    Murray A Freedman, Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey, Women's Health, 2014, 10, 4, 445

    CrossRef

  46. 46
    Elaine W. Flagg, S. Deblina Datta, Mona Saraiya, Elizabeth R. Unger, Edward Peters, Lauren Cole, Vivien W. Chen, Thomas Tucker, Mary Jane Byrne, Glenn Copeland, Won Silva, Meg Watson, Hillard Weinstock, Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009, Cancer Causes & Control, 2014, 25, 5, 571

    CrossRef

  47. You have free access to this content47
    Jacqueline W. Miller, Marcus Plescia, Donatus U. Ekwueme, Public health national approach to reducing breast and cervical cancer disparities, Cancer, 2014, 120, S16
  48. 48
    Tor Haldorsen, Gry Baadstrand Skare, Giske Ursin, Tone Bjørge, Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme, Acta Oncologica, 2014, 1

    CrossRef

  49. 49
    Laurie Elit, Role of cervical screening in older women, Maturitas, 2014, 79, 4, 413

    CrossRef

  50. 50
    Angel Chao, Yun-Hsin Tang, Chyong-Huey Lai, Role of Human Papillomavirus Testing in Screening of Cervical Neoplasia, Current Obstetrics and Gynecology Reports, 2014, 3, 2, 116

    CrossRef

  51. 51
    Ling Zhang, Hui Kong, Chien Ting Chin, Shaoxiong Liu, Zhi Chen, Tianfu Wang, Siping Chen, Segmentation of cytoplasm and nuclei of abnormal cells in cervical cytology using global and local graph cuts, Computerized Medical Imaging and Graphics, 2014, 38, 5, 369

    CrossRef

  52. 52
    H. Xu, Y. Zhang, D. Altomare, M. M. Pena, F. Wan, L. Pirisi, K. E. Creek, Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes, Carcinogenesis, 2014, 35, 6, 1379

    CrossRef

  53. 53
    Erik J. Nelson, John Hughes, Shalini L. Kulasingam, Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998–2007, Spatial and Spatio-temporal Epidemiology, 2014, 9, 13

    CrossRef

  54. 54
    Helen Dinkelspiel, Walter Kinney, State of the Science: Cervical cancer screening in transition, Gynecologic Oncology, 2014, 133, 3, 389

    CrossRef

  55. 55
    Wen Chen, Jose Jeronimo, Fang-Hui Zhao, You-Lin Qiao, Melissa Valdez, Xun Zhang, Le-Ni Kang, Pooja Bansil, Proma Paul, Ping Bai, Roger Peck, Jing Li, Feng Chen, Mark H. Stoler, Philip E. Castle, The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens, Journal of Clinical Virology, 2014, 61, 4, 553

    CrossRef

  56. 56
    Cosette M. Wheeler, William C. Hunt, Jack Cuzick, Erika Langsfeld, Michael Robertson, Philip E. Castle, The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States, International Journal of Cancer, 2014, 135, 3
  57. 57
    Julia C. Gage, Hormuzd A. Katki, Mark Schiffman, Philip E. Castle, Barbara Fetterman, Nancy E. Poitras, Thomas Lorey, Li C. Cheung, Catherine Behrens, Abha Sharma, Fang-Hui Zhao, Jack Cuzick, Zi Hua Yang, Walter K. Kinney, The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management, Cancer Cytopathology, 2014, 122, 11
  58. 58
    Philip E. Castle, William C. Hunt, Erika Langsfeld, Cosette M. Wheeler, Three-Year Risk of Cervical Precancer and Cancer After the Detection of Low-Risk Human Papillomavirus Genotypes Targeted by a Commercial Test, Obstetrics & Gynecology, 2014, 123, 1, 49

    CrossRef

  59. 59
    Eileen M. Burd, Updated Guidelines for Cervical Cancer Screening, Clinical Microbiology Newsletter, 2014, 36, 13, 95

    CrossRef

  60. You have free access to this content60
    Danielle Novetsky Friedman, Eric Lis, Charles A. Sklar, Kevin C. Oeffinger, Marina Reppucci, Megan Harlan Fleischut, Jasmine H. Francis, Brian Marr, David H Abramson, Ira J Dunkel, Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study, Pediatric Blood & Cancer, 2014, 61, 8
  61. 61
    Jugao Fang, Zhigang Huang, Xiaohong Chen, WITHDRAWN: MiR-127 and miR-218 detection in plasma might serve as potential biomarkers of cervical cancer, Biomedicine & Pharmacotherapy, 2014,

    CrossRef

  62. 62
    P. Hillemanns, P. Soergel, M. Jentschke, Zervixkarzinomfrüherkennung, Der Gynäkologe, 2014, 47, 5, 334

    CrossRef

  63. 63
    Sandra D Isidean, Karolina Louvanto, Eduardo L Franco, Advances in Cervical Cancer Management, 2014,

    CrossRef

  64. 64
    ANNA M. PRIEBE, 2012 Cervical Cancer Screening Guidelines and the Future Role of HPV Testing, Clinical Obstetrics and Gynecology, 2013, 56, 1, 44

    CrossRef

  65. 65
    L. Stewart Massad, Mark H. Einstein, Warner K. Huh, Hormuzd A. Katki, Walter K. Kinney, Mark Schiffman, Diane Solomon, Nicolas Wentzensen, Herschel W. Lawson, 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors, Obstetrics & Gynecology, 2013, 121, 4, 829

    CrossRef

  66. 66
    L. Stewart Massad, Mark H. Einstein, Warner K. Huh, Hormuzd A. Katki, Walter K. Kinney, Mark Schiffman, Diane Solomon, Nicolas Wentzensen, Herschel W. Lawson, 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors, Journal of Lower Genital Tract Disease, 2013, 17, S1

    CrossRef

  67. 67
    Insiyyah Y. Patanwala, Heidi M. Bauer, Justin Miyamoto, Ina U. Park, Megan J. Huchko, Karen K. Smith-McCune, A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening, American Journal of Obstetrics and Gynecology, 2013, 208, 5, 343

    CrossRef

  68. 68
    LESLIE A. GARRETT, CHRISTOPHER K. MCCANN, Abnormal Cytology in 2012, Clinical Obstetrics and Gynecology, 2013, 56, 1, 25

    CrossRef

  69. 69
    V. Militello, E. Lavezzo, G. Costanzi, E. Franchin, B. Di Camillo, S. Toppo, G. Palù, L. Barzon, Accurate human papillomavirus genotyping by 454 pyrosequencing, Clinical Microbiology and Infection, 2013, 19, 10
  70. 70
    Judith Lee Smith, Katherine M. Wilson, Carlyn E. Orians, Theresa L. Byrd, AMIGAS: Building a Cervical Cancer Screening Intervention for Public Health Practice, Journal of Women's Health, 2013, 22, 9, 718

    CrossRef

  71. 71
    A. Jemal, E. P. Simard, C. Dorell, A.-M. Noone, L. E. Markowitz, B. Kohler, C. Eheman, M. Saraiya, P. Bandi, D. Saslow, K. A. Cronin, M. Watson, M. Schiffman, S. J. Henley, M. J. Schymura, R. N. Anderson, D. Yankey, B. K. Edwards, Annual Report to the Nation on the Status of Cancer, 1975-2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)-Associated Cancers and HPV Vaccination Coverage Levels, JNCI Journal of the National Cancer Institute, 2013, 105, 3, 175

    CrossRef

  72. 72
    Mark H. Stoler, Thomas C. Wright, Jack Cuzick, Janel Dockter, Jennifer L. Reid, Damon Getman, Cristina Giachetti, APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results, American Journal of Obstetrics and Gynecology, 2013, 208, 2, 144.e1

    CrossRef

  73. You have free access to this content73
    Robert A. Smith, Durado Brooks, Vilma Cokkinides, Debbie Saslow, Otis W. Brawley, Cancer screening in the United States, 2013, CA: A Cancer Journal for Clinicians, 2013, 63, 2
  74. 74
    C. M. Pierce Campbell, M. Darwish-Yassine, S. D. Harlow, C. M. Johnston, M. P. Curado, K. R. Cho, A. S. Soliman, Cervical cancer screening among Michigan women: ‘The Special Cancer Behavioral Risk Factor Survey’, 2004–2008, Journal of Obstetrics & Gynaecology, 2013, 33, 6, 617

    CrossRef

  75. 75
    Nancy K. Lowe, Cervical Cancer Screening Guidelines 2012, Journal of Obstetric, Gynecologic, & Neonatal Nursing, 2013, 42, 1
  76. 76
    Jody Stonehocker, Cervical Cancer Screening in Pregnancy, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 269

    CrossRef

  77. 77
    Caren G. Solomon, Mark Schiffman, Diane Solomon, Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting, New England Journal of Medicine, 2013, 369, 24, 2324

    CrossRef

  78. 78
    Erin Ashton, Amy Brown, James Hoffman, Seema Khutti, Clear cell adenocarcinoma of the uterine cervix in an 18 year-old pregnant female, Gynecologic Oncology Case Reports, 2013, 5, 49

    CrossRef

  79. 79
    Mollie E. Aleshire, Sharon E. Lock, Lynne A. Jensen, College Sorority Members’ Knowledge and Behaviors Regarding Human Papillomavirus and Cervical Cancer, Nursing Clinics of North America, 2013, 48, 2, 215

    CrossRef

  80. 80
    KATHARINE M. ESSELEN, SARAH FELDMAN, Cost-effectiveness of Cervical Cancer Prevention, Clinical Obstetrics and Gynecology, 2013, 56, 1, 55

    CrossRef

  81. 81
    Maria Lina Diaz, Counseling the Patient with HPV Disease, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 391

    CrossRef

  82. 82
    S. D. Isidean, E. L. Franco, Counterpoint: Cervical Cancer Screening Guidelines--Approaching the Golden Age, American Journal of Epidemiology, 2013, 178, 7, 1023

    CrossRef

  83. 83
    Andrea R. Hagemann, Ivy Wilkinson-Ryan, Lindsay M. Kuroki, Kathryn Squires, Discussion: ‘Comparison of cervical cancer screening strategies,' by Cox et al, American Journal of Obstetrics and Gynecology, 2013, 208, 3, e1

    CrossRef

  84. 84
    Aruna Kamineni, Sheila Weinmann, Kirkwood K. Shy, Andrew G. Glass, Noel S. Weiss, Efficacy of screening in preventing cervical cancer among older women, Cancer Causes & Control, 2013, 24, 9, 1653

    CrossRef

  85. 85
    Laura J. Fish, Patricia G. Moorman, Lashawn Wordlaw-Stintson, Adriana Vidal, Jennifer S. Smith, Cathrine Hoyo, Factors Associated With Adherence to Follow-up Colposcopy, American Journal of Health Education, 2013, 44, 6, 293

    CrossRef

  86. 86
    Hormuzd A. Katki, Mark Schiffman, Philip E. Castle, Barbara Fetterman, Nancy E. Poitras, Thomas Lorey, Li C. Cheung, Tina Raine-Bennett, Julia C. Gage, Walter K. Kinney, Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results, Journal of Lower Genital Tract Disease, 2013, 17, S36

    CrossRef

  87. 87
    Philippe Halfon, Maria Luisa Mateos Lindemann, Audrey Raimondo, Sophie Ravet, Claire Camus, Hacène Khiri, Guillaume Pénaranda, Mario Sideri, Maria Teresa Sandri, HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test, Archives of Virology, 2013, 158, 6, 1143

    CrossRef

  88. 88
    Patricia Luhn, Nicolas Wentzensen, HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease, Current Obstetrics and Gynecology Reports, 2013, 2, 2, 76

    CrossRef

  89. 89
    Philip E Castle, Julia C Gage, Edward E Partridge, Alfio Rausa, Patti E Gravitt, Isabel C Scarinci, Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta, BMC Infectious Diseases, 2013, 13, 1, 5

    CrossRef

  90. 90
    P. V. Chin-Hong, E. J. Kwak, Human Papillomavirus in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  91. 91
    Philip E. Castle, Miriam Cremer, Human Papillomavirus Testing in Cervical Cancer Screening, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 377

    CrossRef

  92. 92
    A. C. Rodriguez, D. Solomon, R. Herrero, A. Hildesheim, P. Gonzalez, S. Wacholder, C. Porras, S. Jimenez, M. Schiffman, Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment, American Journal of Epidemiology, 2013, 178, 5, 752

    CrossRef

  93. 93
    Meggan Zsemlye, LSIL, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 283

    CrossRef

  94. 94
    Dong Hoon Suh, Jae-Weon Kim, Kidong Kim, Hak Jae Kim, Kyung-Hun Lee, Major clinical research advances in gynecologic cancer in 2012, Journal of Gynecologic Oncology, 2013, 24, 1, 66

    CrossRef

  95. 95
    Cathy R. Kessenich, Kristi Cronin, Minimizing unnecessary colposcopies and biopsies, The Nurse Practitioner, 2013, 38, 4, 11

    CrossRef

  96. 96
    Leo B. Twiggs, Nahida A. Chakhtoura, Daron G. Ferris, Lisa C. Flowers, Marc L. Winter, Daniel R. Sternfeld, Manocher Lashgari, Alexander F. Burnett, Stephen S. Raab, Edward J. Wilkinson, Multimodal hyperspectroscopy as a triage test for cervical neoplasia: Pivotal clinical trial results, Gynecologic Oncology, 2013, 130, 1, 147

    CrossRef

  97. 97
    Attila Lorincz, Alejandra Castanon, Anita Wey Wey Lim, Peter Sasieni, New strategies for human papillomavirus-based cervical screening, Women's Health, 2013, 9, 5, 443

    CrossRef

  98. 98
    Anne F. Rositch, Jill Koshiol, Michael G. Hudgens, Hilda Razzaghi, Danielle M. Backes, Jeanne M. Pimenta, Eduardo L. Franco, Charles Poole, Jennifer S. Smith, Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis, International Journal of Cancer, 2013, 133, 6
  99. 99
    A. S. Rustagi, A. Kamineni, N. S. Weiss, Point: Cervical Cancer Screening Guidelines Should Consider Observational Data on Screening Efficacy in Older Women, American Journal of Epidemiology, 2013, 178, 7, 1020

    CrossRef

  100. 100
    &NA;, Practice Bulletin No. 140, Obstetrics & Gynecology, 2013, 122, 6, 1338

    CrossRef

  101. 101
    P.A. Tarallo, J. Smolowitz, D. Carriero, J. Tarallo, A. Siegel, H. Jia, J.C. Emond, Prevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation, Transplant Infectious Disease, 2013, 15, 4
  102. 102
    Yun-Jee Kim, Min-Jung Kwon, Hee-Yeon Woo, Soon-Young Paik, Prevalence of human papillomavirus infection and genotype distribution determined by the cyclic-catcher melting temperature analysis in Korean medical checkup population, Journal of Microbiology, 2013, 51, 5, 665

    CrossRef

  103. 103
    Linda R. Duska, Mark H. Stoler, Prevention of human papillomavirus-related malignancy: Access is the answer, Cancer, 2013, 119, 16
  104. 104
    Andrzej Nowakowski, Teresa Jackowska, Przemysław J. Oszukowski, Stanisław Radowicki, Jacek Wysocki, Witold Zatoński, Profilaktyka raka szyjki macicy – problem interdyscyplinarny. Czy i jak możemy poprawić sytuację w Polsce?, Pediatria Polska, 2013, 88, 4, 340

    CrossRef

  105. 105
    Michael Anstead, Sonya L. Heltshe, Umer Khan, Joseph T. Barbieri, Markus Langkamp, Gerd Döring, Shimoni Dharia, Ronald L. Gibson, Miriam M. Treggiari, James Lymp, Margaret Rosenfeld, Bonnie Ramsey, Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial, Journal of Cystic Fibrosis, 2013, 12, 2, 147

    CrossRef

  106. 106
    Jennifer S. Smith, Noel T. Brewer, Debbie Saslow, Kenneth Alexander, Mildred R. Chernofsky, Richard Crosby, Libby Derting, Leah Devlin, Charles J. Dunton, Jeffrey Engle, Maria Fernandez, Mona Fouad, Warner Huh, Walter Kinney, Jennifer Pierce, Elena Rios, Mitchel C. Rothholz, Judith C. Shlay, Rivienne Shedd-Steele, Sally W. Vernon, Joan Walker, Theresa Wynn, Gregory D. Zimet, Baretta R. Casey, Recommendations for a national agenda to substantially reduce cervical cancer, Cancer Causes & Control, 2013, 24, 8, 1583

    CrossRef

  107. 107
    Lori A. Boardman, Katina Robison, Screening Adolescents and Young Women, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 257

    CrossRef

  108. 108
    Jatinderpal K Kalsi, Ranjit Manchanda, Usha Menon, Screening for gynecological cancers, Expert Review of Obstetrics & Gynecology, 2013, 8, 2, 143

    CrossRef

  109. 109
    Liangbin Xia, Jing Gao, Yan Liu, Ke Wu, Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis, Tumor Biology, 2013, 34, 1, 223

    CrossRef

  110. 110
    Suzanne M. Miller, Siu-kuen Azor Hui, Kuang-Yi Wen, John Scarpato, Fang Zhu, Joanne Buzaglo, Enrique E. Hernandez, Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women, Patient Education and Counseling, 2013, 93, 3, 488

    CrossRef

  111. 111
    G. Hoste, K. Vossaert, W. A. J. Poppe, The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening, Obstetrics and Gynecology International, 2013, 2013, 1

    CrossRef

  112. 112
    Carlo A. Liverani, The four steps in the prevention of human papillomavirus-associated neoplasia, Archives of Gynecology and Obstetrics, 2013, 288, 5, 979

    CrossRef

  113. 113
    Sanja Percac-Lima, Carly S. Benner, Raymond Lui, Leslie S. Aldrich, Sarah A. Oo, Nessa Regan, Bruce A. Chabner, The Impact of a Culturally Tailored Patient Navigator Program on Cervical Cancer Prevention in Latina Women, Journal of Women's Health, 2013, 22, 5, 426

    CrossRef

  114. 114
    Nancy Joste, Julie Gober-Wilcox, The Modern Cytology Laboratory, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 199

    CrossRef

  115. 115
    Cosette Marie Wheeler, The Natural History of Cervical Human Papillomavirus Infections and Cervical Cancer, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 165

    CrossRef

  116. 116
    Nicolas Wentzensen, Triage of HPV-positive women in cervical cancer screening, The Lancet Oncology, 2013, 14, 2, 107

    CrossRef

  117. 117
    Jin Hwa Hong, Jae Kwan Lee, Updates of the current screening guidelines for the early detection of cervical cancer, Journal of Gynecologic Oncology, 2013, 24, 3, 212

    CrossRef

  118. 118
    Matthias Jentschke, Siegfried Geyer, Peter Hillemanns, Was brauchen wir, was ist überflüssig?, gynäkologie + geburtshilfe, 2013, 18, 6, 32

    CrossRef

  119. You have free access to this content119
    Masahito Jimbo, Gurpreet K. Rana, Sarah Hawley, Margaret Holmes-Rovner, Karen Kelly-Blake, Donald E. Nease, Mack T. Ruffin, What is lacking in current decision aids on cancer screening?, CA: A Cancer Journal for Clinicians, 2013, 63, 3
  120. 120
    Edgar P. Simard, Deepa Naishadham, Debbie Saslow, Ahmedin Jemal, Age-specific trends in black–white disparities in cervical cancer incidence in the United States: 1975–2009, Gynecologic Oncology, 2012, 127, 3, 611

    CrossRef

  121. 121
    Balaiah Donta, Shahina Begum, Saritha Nair, D.D. Naik, B.N. Mali, Anil Bandiwadekar, Awareness of Cervical Cancer among Couples in a Slum Area of Mumbai, Asian Pacific Journal of Cancer Prevention, 2012, 13, 10, 4901

    CrossRef

  122. You have free access to this content122
    Vilma E. Cokkinides, Priti Bandi, Rebecca L. Siegel, Ahmedin Jemal, Cancer-related risk factors and preventive measures in US Hispanics/Latinos, CA: A Cancer Journal for Clinicians, 2012, 62, 6
  123. 123
    Katherine W Reeves, Kathryn Bacon, Lisa Fredman, Caregiving associated with selected cancer risk behaviors and screening utilization among women: cross-sectional results of the 2009 BRFSS, BMC Public Health, 2012, 12, 1, 685

    CrossRef

  124. 124
    Marc Arbyn, Guglielmo Ronco, Ahti Anttila, Chris J.L.M. Meijer, Mario Poljak, Gina Ogilvie, George Koliopoulos, Pontus Naucler, Rengaswamy Sankaranarayanan, Julian Peto, Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer, Vaccine, 2012, 30, F88

    CrossRef

  125. 125
    Philip E. Castle, Silvia de Sanjosé, You-Lin Qiao, Jerome L. Belinson, Eduardo Lazcano-Ponce, Walter Kinney, Introduction of Human Papillomavirus DNA Screening in the World: 15 Years of Experience, Vaccine, 2012, 30, F117

    CrossRef

  126. 126
    L. Stewart Massad, Gypsyamber DʼSouza, Fang Tian, Howard Minkoff, Mardge Cohen, Rodney L. Wright, Christine Colie, Nancy A. Hessol, Negative Predictive Value of Pap Testing, Obstetrics & Gynecology, 2012, 120, 4, 791

    CrossRef

  127. 127
    Carrie Printz, New cervical cancer screening guidelines published, Cancer, 2012, 118, 10
  128. 128
    Philip E. Castle, Kathleen M. Schmeler, Optimizing cervical cancer prevention strategies in the United States, Gynecologic Oncology, 2012, 127, 3, 437

    CrossRef

  129. 129
    Analía Romina Stormo, Crystale Purvis Cooper, Nikki A. Hawkins, Mona Saraiya, Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women, Preventive Medicine, 2012, 54, 6, 415

    CrossRef

  130. 130
    Helen Dinkelspiel, Barbara Fetterman, Nancy Poitras, Walter Kinney, J. Thomas Cox, Thomas Lorey, Philip E. Castle, Screening history preceding a diagnosis of cervical cancer in women age 65 and older, Gynecologic Oncology, 2012, 126, 2, 203

    CrossRef

  131. 131
    Eduardo L. Franco, Towards more eclectic evidence-based medicine in cancer prevention and control, Preventive Medicine, 2012, 55, 6, 552

    CrossRef